What is the epidemiology of bicuspid aortic valve?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Epidemiology of Bicuspid Aortic Valve

Bicuspid aortic valve (BAV) is the most common congenital cardiac malformation, affecting 0.5-2% of the general population, with a strong male predominance. 1

Population Prevalence

  • BAV occurs in 1-2% of live births, making it the most frequent congenital abnormality affecting the aortic valve and aorta 1, 2, 3, 4, 5
  • The most recent European guidelines (2024) cite a prevalence range of 0.5-2%, reflecting the most current epidemiologic data 1
  • Males are affected approximately 2-3 times more frequently than females 2

Familial Clustering and Inheritance

  • 9% of BAV patients have first-degree relatives who also have bicuspid aortic valves, indicating significant familial clustering 1
  • BAV can be inherited as an autosomal dominant condition in some families, though no single-gene model explains the majority of cases 1
  • Several genes implicated in embryogenesis and cell differentiation have been associated with BAV, but each identified gene accounts for less than 5% of cases 1

Associated Cardiovascular Malformations

While often considered "isolated," BAV frequently occurs with other cardiovascular abnormalities:

  • Aortic coarctation occurs in 4.2-11.8% of BAV patients 6
  • Coronary anomalies are present in 3.6-3.7% of cases 6
  • Patent ductus arteriosus occurs in approximately 3.3% 6
  • Ventricular septal defects are found in 0.5-5.9% 6
  • Mitral valve prolapse occurs in 1.5-1.6% 6

Aortopathy Prevalence

  • Aneurysm prevalence reaches 40% in clinical series and 0.85 per 100 patient-years in population studies 1
  • In surgical series, 20% of BAV patients undergoing valve surgery had concurrent ascending aortic aneurysms requiring repair 1
  • 50% of pediatric BAV patients demonstrate ascending aorta dilatation, with 4% having severe dilatation 4

Aortic Dissection Risk

  • As many as 15% of patients with acute aortic dissection have bicuspid aortic valves, a frequency higher than Marfan syndrome 1
  • Aortic dissection occurred in 12.5% of BAV patients with aortic diameter less than 5 cm, similar to rates seen in Marfan syndrome 1
  • Acute aortic events are 8-10 fold more frequent in BAV patients compared to the general population 1

Age-Related Valve Dysfunction

  • 40% of women and approximately one-third of men over age 70 undergoing aortic valve replacement have BAV disease as the underlying pathology 1
  • Younger patients more commonly present with aortic regurgitation, while older patients more frequently develop aortic stenosis 1
  • BAV accounts for less than 4% of sudden cardiac deaths in young athletes, though it is a recognized cause of exertion-related sudden death 1

Lifetime Morbidity Burden

  • Recent follow-up data shows a total lifetime morbidity burden as high as 86% in BAV patients, predominantly driven by valve-related complications including aortic stenosis 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The bicuspid aortic valve and related disorders.

Sao Paulo medical journal = Revista paulista de medicina, 2010

Research

Genetic insights into bicuspid aortic valve formation.

Cardiology research and practice, 2012

Research

[Bicuspid aortic valve: epidemiology, genetics and clinics].

Recenti progressi in medicina, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.